|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||N/A - N/A|
|52-week range||undefined - undefined|
|PE ratio (TTM)||N/A|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|
Big Pharma Merck is scheduled to report its second-quarter earnings results on July 28. Here are three questions investors are expecting to have answered on that date.
Activist hedge fund Sarissa Capital will nominate two directors to Ariad Pharmaceuticals' board and seek the "imminent retirement" of Chief Executive Harvey Berger.